FPT Digital Retail Joint Stock Company (FRT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
3 Nov, 2026Executive summary
9M 2024 net revenue was VND 28,656,844,381,262, up from VND 23,159,634,593,483 in 9M 2023; net profit after tax was VND 274,552,021,224 versus a loss of VND 225,703,846,242.
Cash and cash equivalents reached VND 2,169,613,383,180 at 30 Sep 2024, compared with VND 960,822,549,973 at 31 Dec 2023.
Financial highlights
9M gross profit was VND 5,508,599,853,727, compared with VND 3,639,020,880,660 in 9M 2023; cost of sales was VND 23,148,244,527,535.
9M operating profit was VND 381,860,300,896, versus an operating loss of VND 202,731,746,879 in 9M 2023; profit before tax was VND 357,609,239,688.
9M net profit attributable to parent shareholders was VND 206,417,963,239, versus a loss of VND 244,766,310,897 in 9M 2023.
Q3 net revenue was VND 10,375,679,031,706; Q3 net profit after tax was VND 165,413,095,580, compared with a loss of VND 13,022,381,327 in Q3 2023.
Segment performance
9M revenue: informatics equipment, telephones, components and accessories VND 10,904,057,544,321; pharmaceutical business VND 18,006,060,701,455; others VND 25,115,383,228; consolidation eliminations VND 278,389,247,742.
Segment profit before interest, taxes, depreciation and amortisation totaled VND 763,880,106,990; pharmaceutical business contributed VND 692,257,471,314 and informatics VND 67,357,850,785.
Pharmaceutical business segment assets were VND 7,945,872,883,080 at 30 Sep 2024; informatics segment assets were VND 7,366,734,594,603.
Latest events from FPT Digital Retail Joint Stock Company
- Parent-attributable loss and negative operating cash flow marked a weak Q1 despite VND 7.753tn revenue.FRT
Q1 2023 - Revenue grew, but H1 swung to operating and net losses.FRT
Q2 2023 - Revenue grew, but 9M 2023 ended in a VND 225.704bn net loss.FRT
Q3 2023 - Revenue increased, but FY2023 ended with a VND 329.2bn net loss and heavy operating cash outflow.FRT
Q4 2023 - Gross profit and operating cash flow improved as revenue fell and losses narrowed.FRT
Q1 2024 - H1 revenue advanced, earnings returned to profit, and operating cash flow strengthened.FRT
Q2 2024 - FY2024 returned to profit despite lower revenue, with year-end cash rising to VND 1.170tn.FRT
Q4 2024 - Q1 net profit reached VND 212.8bn as revenue climbed to VND 11.67tn.FRT
Q1 2025 - H1 profit more than tripled as revenue advanced and pharmaceutical operations led segment results.FRT
Q2 2025